Scienture Holdings Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 9

Employees

  • Stock Symbol
  • SCNX

Stock Symbol

  • Investments
  • 9

  • Share Price
  • $2.28
  • (As of Friday Closing)

Scienture Holdings General Information

Description

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.

Contact Information

Formerly Known As
Bluebird Exploration, Xcellink International, TRxADE Health
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2420 Brunello Trace
  • Lutz, FL 34458
  • United States
+1 (800)
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare Services
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 2420 Brunello Trace
  • Lutz, FL 34458
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scienture Holdings Stock Performance

As of 20-Nov-2026, Scienture Holdings’s stock price is $2.28. Its current market cap is $4.07M with 1.79M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.28 $2.44 $2.00 - $18.75 $4.07M 1.79M 155K -$51.74

Scienture Holdings Financials Summary

As of 30-Sep-2026, Scienture Holdings has a trailing 12-month revenue of $1.65M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 13,170 22,921 54,995 4,498
Revenue 1,655 432 137 1,364
EBITDA (39,497) (39,235) (17,525) (6,294)
Net Income (40,354) (41,512) 9,066 (17,844)
Total Assets 87,184 84,178 104,854 12,533
Total Debt 10,991 24 3,533 210
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Scienture Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Scienture Holdings‘s full profile, request access.

Request a free trial

Scienture Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the c
Other Healthcare Technology Systems
Lutz, FL
9 As of 2025

Irving, TX
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Scienture Holdings Competitors (6)

One of Scienture Holdings’s 6 competitors is McKesson, a Corporation company based in Irving, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
McKesson Corporation Irving, TX
Teladoc Health Formerly VC-backed New York, NY
Cencora Corporation Conshohocken, PA
Doctor On Demand Private Equity-Backed San Francisco, CA
MDLive Venture Capital-Backed Miramar, FL
To view Scienture Holdings’s complete competitors history, request access »

Scienture Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Scienture Holdings Investments & Acquisitions (9)

Scienture Holdings’s most recent deal was a Reverse Merger with Scienture for . The deal was made on 25-Jul-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Scienture 25-Jul-2024 Reverse Merger Drug Discovery
Superlatus 31-Jul-2023 Merger/Acquisition Food Products
SoSRx 15-Feb-2022 Joint Venture Internet Retail
Bonum Health 23-Oct-2019 Merger/Acquisition Other Healthcare Technology Systems
SyncHealth 17-Jan-2019 Joint Venture Vertical Market Software
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Scienture Holdings ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

24.1 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Distribution

Subindustry

of 42

Rank

Percentile

To view Scienture Holdings’s complete esg history, request access »

Scienture Holdings Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Superlatus New York, NY 2022
Scienture New York, NY 2019
Integra Pharma Solutions Tampa, FL 2010

Scienture Holdings FAQs

  • When was Scienture Holdings founded?

    Scienture Holdings was founded in 2010.

  • Where is Scienture Holdings headquartered?

    Scienture Holdings is headquartered in Lutz, FL.

  • What is the size of Scienture Holdings?

    Scienture Holdings has 9 total employees.

  • What industry is Scienture Holdings in?

    Scienture Holdings’s primary industry is Other Healthcare Technology Systems.

  • Is Scienture Holdings a private or public company?

    Scienture Holdings is a Public company.

  • What is Scienture Holdings’s stock symbol?

    The ticker symbol for Scienture Holdings is SCNX.

  • What is the current stock price of Scienture Holdings?

    As of 20-Nov-2026 the stock price of Scienture Holdings is $2.28.

  • What is the current market cap of Scienture Holdings?

    The current market capitalization of Scienture Holdings is $4.07M.

  • What is Scienture Holdings’s current revenue?

    The trailing twelve month revenue for Scienture Holdings is $1.65M.

  • Who are Scienture Holdings’s competitors?

    McKesson, Teladoc Health, Cencora, Doctor On Demand, and MDLive are some of the 6 competitors of Scienture Holdings.

  • What is Scienture Holdings’s annual earnings per share (EPS)?

    Scienture Holdings’s EPS for 12 months was -$51.74.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process